Andrew Klein, MD
Interventional Cardiology · Atlanta, GANPI 1366482424
Payments from drug & device makers
Across 413 payments — averaging $1425.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$352K
- Abbott$60K
- Angiodynamics, Inc.$47K
- Boston Scientific$47K
- Endovascular Engineering Inc.$42K
- Surmodics, Inc.$21K
- plus $19K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 51 | $351,528 |
| Abbott | 51 | $60,489 |
| Angiodynamics, Inc. | 10 | $47,036 |
| Boston Scientific | 50 | $46,910 |
| Endovascular Engineering Inc. | 17 | $42,278 |
| Surmodics, Inc. | 73 | $21,292 |
| Intact Vascular, Inc. | 3 | $12,020 |
| Cardiovascular Systems Inc. | 19 | $2,257 |
| Datascope Corp. | 1 | $1,200 |
| Novartis | 52 | $950 |
| Johnson & Johnson | 37 | $667 |
| Medtronic | 11 | $489 |
| Abiomed | 4 | $405 |
| Edwards Lifesciences | 4 | $160 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $149 |
| Chiesi USA, Inc. | 1 | $133 |
| EKOS Corporation | 1 | $112 |
| Amgen | 5 | $96 |
| Amarin Pharma, Inc. | 5 | $93 |
| E.r. Squibb & Sons, L.L.C. | 4 | $79 |
| AstraZeneca | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 2 | $35 |
| Bridgebio Pharma, Inc. | 2 | $32 |
| Pfizer | 1 | $30 |
| Biotronik Inc. | 2 | $30 |
| Asahi Intecc USA, Inc. | 1 | $14 |
| Reflow Medical Inc | 1 | $14 |
How this compares
$588,536 in reported general payments places this provider in the 90th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Atlanta
- David KandzariAtlanta$3.7M
- Pradeep YadavAtlanta$3.5M
- Vasilis BabaliarosAtlanta$2.7M
- William NicholsonAtlanta$2M
- Chandanreddy DevireddyAtlanta$1.9M
- Adam GreenbaumAtlanta$1.8M
- Vivek RajagopalAtlanta$1.3M
- Christopher MeduriAtlanta$1.1M
- Wissam JaberAtlanta$981K
- George HanzelAtlanta$750K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.